Your session is about to expire
← Back to Search
ZW25 for Endometrial Cancer
Study Summary
This trial is looking at whether ZW25 is effective for treating HER2-overexpressed endometrial cancer or carcinosarcoma in women who have been treated in the past.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have or had inflammatory bowel disease.My endometrial cancer is HER2 positive.I stopped any radiation therapy at least 4 weeks ago.I am not pregnant, breastfeeding, and if I can bear children, I use effective birth control.I do not have severe numbness or pain in my hands or feet.I have not had a heart attack or unstable chest pain in the last 6 months.I do not have any severe illnesses that are not under control.I am HIV positive.I had hepatitis B but it's resolved, or I have hepatitis C but no active virus.I haven't taken any antibiotics by mouth or IV in the last 2 weeks.I have had cancer before, but it meets the trial's exceptions.I have had a blockage in my intestines within the last 3 months.I am 18 years old or older.I am fully active or restricted in physically strenuous activity but can do light work.I haven't had any severe infections or been hospitalized for them in the last 4 weeks.I have had 1 or 2 chemotherapy treatments for endometrial cancer.I have not received a live vaccine in the last 4 weeks and do not plan to during the study.I do not have untreated brain metastases needing medication for symptoms.I have at least one tumor that can be clearly measured.I have not had a bowel perforation, fistula, or abscess in the last 3 months.I have heart failure but no serious irregular heartbeats.I received my last cancer treatment less than 3 weeks ago.My blood, liver, heart, and kidney functions are all within normal ranges.I do not have any infections needing antibiotics, except maybe a simple UTI.I have had a stroke in the last six months.My side effects from recent cancer treatment are mild or gone, except for hair loss.I haven't had major surgery or significant injury in the last 28 days and don't expect to need major surgery during the study.I have not had high doses of anthracycline or any in the last 3 months.I need frequent procedures to remove excess fluid from my abdomen.My diagnosis of endometrial cancer or carcinosarcoma is confirmed by tissue analysis.I agree to abstain from sexual activity if it aligns with my usual lifestyle.
- Group 1: Stage 1
- Group 2: Stage 2
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants is the team seeking to include in this research endeavor?
"Affirmative. According to clinicaltrials.gov, this investigation is currently recruiting patients having been initially posted on 12th August 2020 and last updated 11th January 2022. 25 participants are needed from 7 healthcare facilities in total."
Has the Food and Drug Administration sanctioned ZW25?
"Even though the efficacy of ZW25 has yet to be established, there is enough evidence that confirms its safety to rate it a 2 on our scale."
Are there any vacancies for participants at this research trial?
"Affirmative. According to clinicaltrials.gov, the trial which was initially posted on August 12th 2020 is currently recruiting participants for a study involving 25 patients located at 7 distinct sites."
In what geographic locations is this research endeavor taking place?
"Currently, seven medical centres are actively recruiting for this trial - including Memorial Sloan Kettering Nassau (limited protocol activities) in Rockville Centre and Memoral Sloan Kettering Westchester (limited protocol activities) in Harrison. Additionally, there are four other locations also participating."
Share this study with friends
Copy Link
Messenger